Use of IVIG and salmeterol in Wilson-Mikity syndrome.
Ng
D K
DK
D000420:Albuterol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007231:Infant, Newborn; D007234:Infant, Premature; D012131:Respiratory Insufficiency / Q000151:congenital / Q000628:therapy*; D000068299:Salmeterol Xinafoate; D013577:Syndrome
D001993:Bronchodilator Agents; D016756:Immunoglobulins, Intravenous; D000068299:Salmeterol Xinafoate; D000420:Albuterol